FDA says it’s “become aware of the risk of T cell malignancies” following “treatment with BCMA- and CD19-directed genetically modified autologous T cell immunotherapies.”

Nothing like gene therapy to give you cancer.

— zerohedge (@zerohedge) January 22, 2024